ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag lipoprotein lipase deficiency disease medicine cell molecular biology

Eat Yourself to Live: Autophagy’s Role in Health and Disease
Vikramjit Lahiri and Daniel J. Klionsky | Mar 1, 2018 | 10+ min read
New details of the molecular process by which our cells consume themselves point to therapeutic potential.
T Cells and Neurons Talk to Each Other
Ashley Yeager | Oct 1, 2020 | 10+ min read
Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.
Gladstone Foundation Establishes Niche In Heart Research
Frederic Golden | Apr 29, 1990 | 6 min read
Bequest by developer turns into $118 million endowment to fund work on the molecular bases of heart disease SAN FRANCISCO -- When Southern California shopping center developer J. David Gladstone died while swimming in the pool of his Hollywood Hills home in 1971, his death got scant notice beyond local real estate circles. Yet today the memory of this obscure businessman lives on among biomedical scientists as the benefactor of the J. David Gladstone Foundation. The spectacular growth and sci
Let It Shine
Jorge Cortese | Mar 19, 2000 | 9 min read
Fluorescence Detection Products Courtesy of BD PharMingenMulticolor immunofluorescent cell staining showing cell surface FITC (green) staining and intracellular PE (orange) and APC (red) staining. Is radioactive detection of biomolecules destined to the same fate as the Berlin Wall? The multitude of nonisotopic detection methods now available suggests that the 21st century may come to be billed as the "nonisotopic research century." The broadest common denominator of this up and coming cast of
Gene Therapy: Clinical Gains Yield A Wealth Of Research Opportunities
Franklin Hoke | Oct 3, 1993 | 8 min read
investigation that will carry advances forward The transfer of genetic materials into humans to correct diseases--gene therapy--is a new medical enterprise, barely three years old in the clinic. But in the short time since a research team at the National Institutes of Health in Bethesda, Md., first treated a young girl's genetically compromised immune system with a transfusion of her own DNA-corrected white blood cells on Sept. 14, 1990, gene therapy has grown to command considerable public
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Preimplantation Genetic Diagnosis: The Next Big Thing?
Ricki Lewis | Nov 12, 2000 | 9 min read
Courtesy of David Hill, ART Reproductive Center Inc.Two separated blastomeres subjected to FISH analysis to check the chromosomes. In early October, preimplantation genetic diagnosis (PGD) made headlines when a Colorado couple used assisted reproductive technology (ART) to have a baby named Adam, whose umbilical cord stem cells could cure his six-year-old sister Molly's Fanconi anemia.1 When Adam Nash was a ball of blastomere cells, researchers at the Reproductive Genetics Institute at Illinois
Mafia Wars
Jef Akst | May 31, 2010 | 10+ min read
An increasing amount of data is showing that the cellular battle between pathogens and hosts needs much more than a simple military metaphor to describe it—think undercover infiltration, front organizations, and forced suicide.
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Soybeans Hit Main Street
Barry Palevitz | Mar 19, 2000 | 8 min read
Once a favorite of Chinese emperors, tofu is now big time. From supermarkets to health food boutiques, diet-conscious Americans are buying soybeans, not just as tofu but in infant formula, soy milk, and soy burgers. Soy even has the Food and Drug Administration's seal of approval. Last October the FDA responded to a petition by Protein Technologies International, a St. Louis-based DuPont company specializing in soy products, by authorizing claims that soy protein is good for the heart. Acc

Run a Search

ADVERTISEMENT